Kozlowski C M, Green A, Grundy D, Boissonade F M, Bountra C
Neuroscience Unit, GlaxoWellcome Research and Development, Stevenage SG1 2NY, UK.
Gut. 2000 Apr;46(4):474-80. doi: 10.1136/gut.46.4.474.
Noxious intestinal distention elicits a reflex depressor response in the sodium pentobarbitone anaesthetised rat, which can be used as an index of visceral nociception. 5-HT(3) receptor antagonists inhibit this reflex. Repeated colorectal distention (CRD) induces Fos like immunoreactivity (Fos-LI) in the rat spinal cord.
To examine the effect of the 5-HT(3) receptor antagonist alosetron on the depressor response to CRD, and on Fos expression in the lumbosacral spinal cord.
Male rats were anaesthetised with sodium pentobarbitone, and mean arterial blood pressure monitored during repeated colorectal balloon inflation before and after treatment with alosetron or saline. Rats anaesthetised with urethane and treated with alosetron or saline underwent a repeated CRD paradigm, after which the lumbosacral spinal cord was removed and processed for visualisation of Fos-LI.
CRD elicited reproducible, volume dependent falls in arterial blood pressure, and repeated distention-effect curves were constructed. Alosetron (1-100 microg/kg intravenously) inhibited the depressor response to CRD in a dose related manner, with an ID(50) value of 3.0 microg/kg. Following repeated CRD, numbers of Fos-LI neurones were significantly increased to 1246 (total in 12 sections at 120 microm intervals from L6 to S1) compared with 49 in sham distended animals. Pretreatment with alosetron (100 microg/kg) significantly reduced numbers of Fos-LI neurones to 479.8.
The 5-HT(3) receptor antagonist alosetron inhibits the depressor response to CRD in a potent and dose dependent manner. It also inhibits CRD induced Fos-LI in the spinal cord. These results suggest that 5-HT(3) receptors are involved in visceral nociceptive transmission, perhaps located on primary afferent or spinal neurones.
在戊巴比妥钠麻醉的大鼠中,有害的肠道扩张会引发反射性降压反应,该反应可作为内脏痛觉的指标。5-羟色胺(5-HT)3受体拮抗剂可抑制此反射。反复结直肠扩张(CRD)可诱导大鼠脊髓中Fos样免疫反应性(Fos-LI)。
研究5-HT3受体拮抗剂阿洛司琼对CRD降压反应及腰段脊髓Fos表达的影响。
雄性大鼠用戊巴比妥钠麻醉,在阿洛司琼或生理盐水处理前后,重复进行结直肠球囊充气时监测平均动脉血压。用乌拉坦麻醉并用阿洛司琼或生理盐水处理的大鼠接受重复CRD范式,之后取出腰段脊髓并进行处理以观察Fos-LI。
CRD引起可重复的、与容量相关的动脉血压下降,并构建了重复扩张效应曲线。阿洛司琼(静脉注射1-100微克/千克)以剂量相关方式抑制对CRD的降压反应,半数抑制剂量(ID50)值为3.0微克/千克。反复CRD后,Fos-LI神经元数量显著增加至1246个(从L6到S1以120微米间隔的12个切片中的总数),而假扩张动物中为49个。阿洛司琼(100微克/千克)预处理显著将Fos-LI神经元数量减少至479.8个。
5-HT3受体拮抗剂阿洛司琼以强效且剂量依赖的方式抑制对CRD的降压反应。它还抑制CRD诱导的脊髓Fos-LI。这些结果表明5-HT3受体参与内脏痛觉传递,可能位于初级传入或脊髓神经元上。